BioMarin

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade BioMarin 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMRN

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. 

CEO
Alexander Hardy
CEOAlexander Hardy
Employees
3,040
Employees3,040
Headquarters
San Rafael, California
HeadquartersSan Rafael, California
Founded
1997
Founded1997
Employees
3,040
Employees3,040

BMRN Key Statistics

Market cap
12.34B
Market cap12.34B
Price-Earnings ratio
24.01
Price-Earnings ratio24.01
Dividend yield
Dividend yield
Average volume
2.52M
Average volume2.52M
High today
$65.95
High today$65.95
Low today
$63.29
Low today$63.29
Open price
$64.02
Open price$64.02
Volume
1.46M
Volume1.46M
52 Week high
$73.51
52 Week high$73.51
52 Week low
$50.76
52 Week low$50.76

Stock Snapshot

The current BioMarin(BMRN) stock price is $64.22, with a market capitalization of 12.34B. The stock trades at a price-to-earnings (P/E) ratio of 24.01.

As of 2026-02-23, BioMarin(BMRN) stock has fluctuated between $63.29 and $65.95. The current price stands at $64.22, placing the stock +1.5% above today's low and -2.6% off the high.

The BioMarin(BMRN)'s current trading volume is 1.46M, compared to an average daily volume of 2.52M.

In the last year, BioMarin(BMRN) shares hit a 52-week high of $73.51 and a 52-week low of $50.76.

In the last year, BioMarin(BMRN) shares hit a 52-week high of $73.51 and a 52-week low of $50.76.

BMRN News

TipRanks 5d
BioMarin price target raised to $75 from $70 at Wells Fargo

Wells Fargo raised the firm’s price target on BioMarin (BMRN) to $75 from $70 and keeps an Overweight rating on the shares. The firm thinks upcoming Transcon-CN...

Analyst ratings

78%

of 27 ratings
Buy
77.8%
Hold
22.2%
Sell
0%

People also own

Based on the portfolios of people who own BMRN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.